Unmodified cell‐free hemoglobin (Hb) is structurally unstable when transfused into the blood stream (Valeri et al., Artif Cells Blood Substit Immobil Biotechnol. 2000;28:451‐475; Chan et al., Toxicol Pathol. 2000;28:635‐642; Eike, Dissertation, 2005; Eike and Palmer, Biotechnol Prog. 2004;20:946‐952). This review examines some of the latest chemical strategies used over the last 5 years to intra‐ and intermolecularly cross‐link Hb, thereby stabilizing its quaternary structure. Therefore, this work will address the following aspects: (1) site‐specific chemical modifications of Hb and (2) non‐site‐specific chemical modifications of Hb, including, but not limited to, PolyHeme®, Hemopure®, Oxyglobin®, and SOD‐Hb. Current strategies for synthesizing PEGylated Hb is outside the scope of this review and will not be discussed herein. For a more thorough review of PEGylated Hb, the reader is directed to the following works: Cabrales and Friedman, Transfus Alternatives in Transfus Med. 2007;9:281–293 and Winslow, Biochim Biophys Acta, 2008;1784(10):1382–1386.